217 related articles for article (PubMed ID: 33187031)
1. Dermatomyositis during COVID-19 Pandemic (A Case Series): Is there a Cause Effect Relationship?
Gokhale Y; Patankar A; Holla U; Shilke M; Kalekar L; Karnik ND; Bidichandani K; Baveja S; Joshi A
J Assoc Physicians India; 2020 Nov; 68(11):20-24. PubMed ID: 33187031
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Tavoni A; Cecchetti R; Guiducci S; Ursini F; Caminiti M; Varcasia G; Gigliotti P; Pellegrini R; Olivo D; Colaci M; Murdaca G; Brittelli R; Mariano GP; Spinella A; Bellando-Randone S; Aiello V; Bilia S; Giannini D; Ferrari T; Caminiti R; Brusi V; Meliconi R; Fallahi P; Antonelli A;
Clin Rheumatol; 2020 Nov; 39(11):3195-3204. PubMed ID: 32852623
[TBL] [Abstract][Full Text] [Related]
3. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection.
Bonometti R; Sacchi MC; Stobbione P; Lauritano EC; Tamiazzo S; Marchegiani A; Novara E; Molinaro E; Benedetti I; Massone L; Bellora A; Boverio R
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9695-9697. PubMed ID: 33015814
[TBL] [Abstract][Full Text] [Related]
4. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
Peschken CA
J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
[No Abstract] [Full Text] [Related]
5. Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A; Moi L; Ribi C; Comte D
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32376774
[No Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32518172
[TBL] [Abstract][Full Text] [Related]
7. No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
So H; Mak JWY; Tam LS
J Rheumatol; 2020 Oct; 47(10):1591. PubMed ID: 32482653
[No Abstract] [Full Text] [Related]
8. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
9. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?
Elefante E; Tani C; Zucchi D; Signorini V; Ferro F; Mosca M
Clin Exp Rheumatol; 2020; 38(3):577. PubMed ID: 32456766
[No Abstract] [Full Text] [Related]
10. A hundred days into the coronavirus disease (COVID-19) pandemic.
Steffens I
Euro Surveill; 2020 Apr; 25(14):. PubMed ID: 32290905
[No Abstract] [Full Text] [Related]
11. No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance.
Capalbo C; Bertamino E; Zerbetto A; Santino I; Petrucca A; Mancini R; Bonfini R; Alfonsi V; Ferracuti S; Marchetti P; Simmaco M; Orsi GB; Napoli C
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33207548
[TBL] [Abstract][Full Text] [Related]
12. Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.
Hayden A; Vyas-Lahar A; Rella V; Rudinskaya A
Lupus; 2020 Oct; 29(11):1472-1474. PubMed ID: 32640936
[TBL] [Abstract][Full Text] [Related]
13. Respiratory and ventilator management of COVID-19.
Khan NA; Akhtar J
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S60-S63. PubMed ID: 32515384
[TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of SARS-CoV in the context of COVID-19 pandemic.
Bhattacharya S; Basu P; Poddar S
J Prev Med Hyg; 2020 Jun; 61(2):E130-E136. PubMed ID: 32802995
[TBL] [Abstract][Full Text] [Related]
15. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
[TBL] [Abstract][Full Text] [Related]
18. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic.
Khavandi S; Tabibzadeh E; Naderan M; Shoar S
Cont Lens Anterior Eye; 2020 Jun; 43(3):211-212. PubMed ID: 32354654
[No Abstract] [Full Text] [Related]
19. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
20. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
Lvov DK; Alkhovsky SV
Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
